Cargando…

Re: Early administration of tocilizumab in hospitalized COVID-19 patients with elevated inflammatory markers; COVIDSTORM

Detalles Bibliográficos
Autores principales:	Klopfenstein, Timothée, Gendrin, Vincent, Zayet, Souheil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212356/ https://www.ncbi.nlm.nih.gov/pubmed/35738319 http://dx.doi.org/10.1016/j.cmi.2022.06.013

Ejemplares similares

‘Early administration of tocilizumab in hospitalized COVID-19 patients with elevated inflammatory markers; COVIDSTORM’ – Author's reply
por: Broman, Niklas, et al.
Publicado: (2022)

Is There Still a Place for Tocilizumab in Coronavirus Disease 2019?
por: Klopfenstein, Timothée, et al.
Publicado: (2021)

Lactobacillus rhamnosus a cause of Gram-positive rods bacteremia after prophylactic probiotic consumption
por: Zayet, Souheil, et al.
Publicado: (2023)

Early administration of tocilizumab in hospitalized COVID-19 patients with elevated inflammatory markers; COVIDSTORM—a prospective, randomized, single-centre, open-label study
por: Broman, Niklas, et al.
Publicado: (2022)

Increased COVID-19 Severity among Pregnant Patients Infected with SARS-CoV-2 Delta Variant, France
por: Zayet, Souheil, et al.
Publicado: (2022)

Natural history of COVID-19: back to basics
por: Zayet, S., et al.
Publicado: (2020)

Shigella sonnei, an emerging multidrug-resistant sexually transmitted pathogen in Franche-Comté, France
por: Zayet, Souheil, et al.
Publicado: (2021)

A Comparative Systematic Review of COVID-19 and Influenza
por: Osman, Molka, et al.
Publicado: (2021)

Simultaneous co-infection with Omicron (B.1.1.529) and Delta (21A/478K.V1) SARS-CoV-2 variants confirmed by whole genome sequencing
por: Zayet, Souheil, et al.
Publicado: (2022)

Asymptomatic cerebral abscesses after pleuropulmonary Nocardia farcinica infection
por: Zayet, S., et al.
Publicado: (2020)

Distinguishing coronavirus disease 2019 from influenza in children remains challenging
por: Zayet, S., et al.
Publicado: (2021)

Recurrence of COVID-19 after recovery ? A case series in health care workers, France
por: Zayet, Souheil, et al.
Publicado: (2021)

Recurrent obstructive prostatitis revealing granulomatosis with polyangiitis
por: Clerc, Melitine, et al.
Publicado: (2021)

Impact of tocilizumab on mortality and/or invasive mechanical ventilation requirement in a cohort of 206 COVID-19 patients
por: Klopfenstein, Timothée, et al.
Publicado: (2020)

COVID-19: comparative clinical features and outcome in 114 patients with or without pneumonia (Nord Franche-Comte Hospital, France)
por: Kadiane-Oussou, N’dri Juliette, et al.
Publicado: (2020)

Atypical miller-fisher syndrome after COVID-19 and sleeve gastrectomy: Contribution of neurochemical markers to early diagnosis
por: Zayet, Souheil, et al.
Publicado: (2022)

Efficacy and Safety of Oral Fosfomycin-Trometamol in Male Urinary Tract Infections with Multidrug-Resistant Enterobacterales
por: Bouiller, Kévin, et al.
Publicado: (2022)

Antibiotics and Therapeutic Agent Prescription in COVID-19 Management
por: Zayet, Souheil, et al.
Publicado: (2022)

Diarrhea: An underestimated symptom in Coronavirus disease 2019
por: Klopfenstein, Timothée, et al.
Publicado: (2020)

Predictive factors of mortality in patients treated with tocilizumab for acute respiratory distress syndrome related to coronavirus disease 2019 (COVID-19)
por: Lohse, Anne, et al.
Publicado: (2020)

Acute Cerebral Stroke with Multiple Infarctions and COVID-19, France, 2020
por: Zayet, Souheil, et al.
Publicado: (2020)

Clinical spectrum of ocular manifestations in COVID-19: a case series
por: Zayet, Souheil, et al.
Publicado: (2023)

Pneumopathies graves liées au COVID-19 : facteurs prédictifs de mortalité après traitement par tocilizumab
por: Kadiane-Oussou, N., et al.
Publicado: (2020)

Systematic Review and Subgroup Meta-analysis of Randomized Trials to Determine Tocilizumab’s Place in COVID-19 Pneumonia
por: Klopfenstein, Timothée, et al.
Publicado: (2021)

Campylobacter fetus Invasive Infections and Risks for Death, France, 2000–2021
por: Zayet, Souheil, et al.
Publicado: (2023)

Angioedema and COVID-19: A New Dermatological Manifestation?
por: Royer, Pierre-Yves, et al.
Publicado: (2021)

New loss of smell and taste: Uncommon symptoms in COVID-19 patients on Nord Franche-Comte cluster, France
por: Klopfenstein, Timothée, et al.
Publicado: (2020)

Clinical features of COVID-19 and influenza: a comparative study on Nord Franche-Comte cluster
por: Zayet, Souheil, et al.
Publicado: (2020)

Orf Nodule with Erythema Multiforme during a Monkeypox Outbreak, France, 2022
por: Cavalieri, Charlotte, et al.
Publicado: (2023)

COVEVOL: Natural Evolution at 6 Months of COVID-19
por: Messin, Louise, et al.
Publicado: (2021)

Leclercia adecarboxylata as Emerging Pathogen in Human Infections: Clinical Features and Antimicrobial Susceptibility Testing
por: Zayet, Souheil, et al.
Publicado: (2021)

Contribution of anosmia and dysgeusia for diagnostic of COVID-19 in outpatients
por: Zayet, Souheil, et al.
Publicado: (2020)

Streptococcus dysgalactiae-related intrathecal baclofen therapy infection: how to avoid withdrawal?
por: De Larminat, V., et al.
Publicado: (2021)

Cohorte de 206 patients avec pneumopathie à SARS-CoV-2 : le tocilizumab diminue la mortalité et/ou le recours à la ventilation mécanique invasive
por: Klopfenstein, T., et al.
Publicado: (2020)

Tocilizumab administration in a refractory case of COVID-19
por: Dastan, Farzaneh, et al.
Publicado: (2020)

Prolonged SARS-CoV-2 Infection in Patients Receiving Anti-CD20 Monoclonal Antibodies: A Diagnostic Challenged by Negative Nasopharyngeal RT-PCR and Successful Treatment with COVID-19 High-Titer Convalescent Plasma
por: Da Silva, Léa, et al.
Publicado: (2023)

Coronavirus disease 2019 with spontaneous pneumothorax, pneumomediastinum and subcutaneous emphysema, France
por: Zayet, S., et al.
Publicado: (2020)

Interleukin 6 levels after tocilizumab administration in transplant recipients with COVID-19
por: Gade, Akhil R., et al.
Publicado: (2020)

Sensibilité, spécificité et valeurs prédictives des signes fonctionnels de l’infection par SARS-CoV-2
por: Zayet, S., et al.
Publicado: (2020)

Tocilizumab therapy reduced intensive care unit admissions and/or mortality in COVID-19 patients
por: Klopfenstein, T., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_p82sk75dd69i7ceai1uli10c66